1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Glaukos Corporation

Glaukos (www.glaukos.com) is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. Glaukos launched the iStent, its first MIGS device, in the United States in 2012, its next-generation iStent inject device in the United States in 2018, and most recently, the iStent inject W device in 2020. In corneal health, Glaukos' proprietary suite of single-use, bio-activated pharmaceuticals are designed to strengthen, stabilize and reshape the cornea through a process called corneal collagen cross-linking to treat corneal ectatic disorders and correct refractive conditions. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies in glaucoma, corneal health and retinal disease.
Thomas Burns

229 Avenida Fabricante
San Clemente, California 92672-7531
Phone: 19493679600


Glaukos (NYSE:GKOS) Rating Increased to Hold at StockNews.com
Oct 01, 2023 08:34am

StockNews.com upgraded shares of Glaukos (NYSE:GKOS – Free Report) from a sell rating to a hold rating in a research report report published on Wednesday morning. A number of other research analysts have also issued reports on GKOS. Citigroup boosted their target price on Glaukos from $59.00 to $85.00 in a report on Monday, July […]

Source:The AM Reporter
Liberty All-Star® Growth Fund, Inc. August 2023 Monthly Update
Sep 15, 2023 14:55pm

BOSTON , Sept. 15, 2023 /PRNewswire/ -- Below is the August 2023 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG ) Liberty All-Star Growth Fund, Inc. Ticker: ASG Monthly Update, August, 2023 Investment Approach: Fund Style: All-Cap Growth Fund Strategy: Combines three growth style investment managers, each with a distinct capitalization focus (small-, mid- and large-cap) selected and continuously monitored by the Fund''s Investment Advisor. Investment Managers: Weatherbie Capital, LLC Small-Cap Growth Congress Asset Management Company, LLP Mid-Cap Growth Sustainable Growth Advisers, LP Large-Cap Growth Top 20 Holdings at Month-End (32.8% of equity portfolio) 1 SPS Commerce, Inc. 2.5 % 2 Microsoft Corp. 2.2 % 3 Amazon.com, Inc. 2.1 % 4 Visa, Inc. 1.9 % 5 Flywire Corp. 1.8 % 6 FirstService Corp. 1.8 % 7 Glaukos Corp. 1.7 % 8 Progyny, Inc. 1.7 % 9 SiteOne Landscape Supply, Inc. 1.6 % 10 Workday, Inc. … Full story available on Benzinga.com

Glaukos Co. (NYSE:GKOS) Shares Sold by Bank of New York Mellon Corp
Aug 28, 2023 09:06am

Bank of New York Mellon Corp trimmed its stake in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 2.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 440,509 shares of the medical instruments supplier’s stock after selling 9,500 shares during the quarter. Bank […]

Source:The AM Reporter
Glaukos Corporation (GKOS) Q2 2023 Earnings Call Transcript
Aug 03, 2023 01:30am

Glaukos Corporation (NYSE:NYSE:GKOS) Q2 2023 Earnings Conference Call August 2, 2023 4:30 PM ETCompany ParticipantsChristopher Lewis - VP, IR & Corporate AffairsThomas Burns - Chairman…

Source:Seeking Alpha